"Tom Abate's reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner." --Thom Calandra, editor in chief, "CBS MarketWatch" In" The Biotech Investor," "San Francisco Chronicle" biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for- tracking the effect of breaking news and the NASDAQ- anticipating drug trial announcements and FDA approvals- assessing the potential market, patent rights, and distribution deals for a drugHe looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. "The Biotech Investor" is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.
具体描述
读后感
用户评价
相关图书
本站所有内容均为互联网搜索引擎提供的公开搜索信息，本站不存储任何数据与内容，任何内容与数据均与本站无关，如有需要请联系相关搜索引擎包括但不限于百度，google,bing,sogou 等
© 2025 onlinetoolsland.com All Rights Reserved. 本本书屋 版权所有